id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-2002-2038,FDA,FDA-2015-N-2002,Request for Extension from Medical Information Working Group (MIWG),Other,Request for Extension,2020-12-15T05:00:00Z,2020,12,2020-12-15T05:00:00Z,,2020-12-15T22:20:25Z,,0,0,09000064848b8379
FDA-2015-N-2002-2037,FDA,FDA-2015-N-2002,Request for Extension from Advanced Medical Technology Association (AdvaMed),Other,Request for Extension,2020-12-15T05:00:00Z,2020,12,2020-12-15T05:00:00Z,,2020-12-15T22:18:20Z,,0,0,09000064848a3295
FDA-2015-N-2002-2036,FDA,FDA-2015-N-2002,Intended Use PR - Response to MIWG Request to Extend Comment Period,Other,Letter(s),2020-11-17T05:00:00Z,2020,11,2020-11-17T05:00:00Z,,2020-11-17T15:01:04Z,,0,0,09000064849619c9
FDA-2015-N-2002-2035,FDA,FDA-2015-N-2002,Intended Use PR - Response to AdvaMed Request to Extend Comment Period,Other,Letter(s),2020-11-17T05:00:00Z,2020,11,2020-11-17T05:00:00Z,,2020-11-17T15:00:53Z,,0,0,09000064849619c7
FDA-2015-N-2002-2031,FDA,FDA-2015-N-2002,"REFERENCE 1 - Plaintiff’s Memorandum of Law at 38–40, Allergan Inc. v. United States RE Regulations Regarding Intended Uses",Supporting & Related Material,Background Material,2020-09-23T04:00:00Z,2020,9,,,2020-09-23T16:38:10Z,,0,0,0900006484873dc9
FDA-2015-N-2002-2034,FDA,FDA-2015-N-2002,"REFERENCE 10 - Eguale, T., D.L. Buckeridge, A. Verma, et al RE Regulations Regarding Intended Uses",Supporting & Related Material,Background Material,2020-09-23T04:00:00Z,2020,9,,,2020-09-23T16:38:36Z,,0,0,0900006484873f3b
FDA-2015-N-2002-2032,FDA,FDA-2015-N-2002,"REFERENCE 2 -  Complaint at 35–37, Par Pharmaceutical Inc. v. United States RE Regulations Regarding Intended Uses",Supporting & Related Material,Background Material,2020-09-23T04:00:00Z,2020,9,,,2020-09-23T16:38:19Z,,0,0,0900006484873dca
FDA-2015-N-2002-2030,FDA,FDA-2015-N-2002,Regulations Regarding Intended Uses,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2020-09-23T04:00:00Z,2020,9,2020-09-23T04:00:00Z,2020-10-24T03:59:59Z,2020-12-16T02:02:47Z,2020-20437,0,0,0900006484872e2d
FDA-2015-N-2002-2033,FDA,FDA-2015-N-2002,REFERENCE 3 -  Citizen Petition from the Medical Information Working Group at 18 RE Regulations Regarding Intended Uses,Supporting & Related Material,Background Material,2020-09-23T04:00:00Z,2020,9,,,2020-09-23T16:38:27Z,,0,0,0900006484873dcb